by Michael Nevradakis, Ph.D., Childrens Health Defense:

After a series of lawsuits alleging Roundup caused cancer led to high-dollar judgments against Bayer, the company is lobbying state legislatures to shield it from future lawsuits and to annul at least some of the 50,000 claims that are currently active, according to a New Republic report.

In 2018, German pharmaceutical giant Bayer acquired Monsanto, producer of the controversial pesticide Roundup, in a $63 billion all-cash deal described at the time as an “important milestone toward the vision of creating a leading agricultural company.”